XM does not provide services to residents of the United States of America.

Deals of the day-Mergers and acquisitions



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Deals of the day-Mergers and acquisitions</title></head><body>

Adds: Masimo, Devon Energy, Vista Outdoor, Eli Lilly, Thermo Fisher Scientific's Updates: Paramount Global, Carlsberg, Grifols

July 8 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:


** Masimo MASI.O said a potential partner is prepared to offer $850 million to $950 million for its consumer business.

nL4N3J00ZK


** Skydance Media and Paramount Global PARA.O agreed to merge, the companies announced late on Sunday, scripting a new chapter for one of Hollywood's oldest studios.

nL1N3IZ075


** Devon Energy DVN.N said it had entered into a deal to acquire private equity firm EnCap-owned Grayson Mill Energy's Williston basin business in a cash-and-stock deal worth $5 billion, as it aims to cash in on high stock valuations to grow acreage.

nL4N3J00T0

** Vista Outdoor VSTO.N rejected investment firm MNC Capital's final buyout offer of $3.2 billion, citing that it undervalued the company, and said it had agreed to an increased bid for its ammunition unit from Czechoslovak Group (CSG).

nL4N3J00OM

** Eli Lilly LLY.N will acquire Morphic Holding MORF.O for $3.2 billion in cash, the companies said , giving the U.S. drugmaker access to an experimental drug for types of inflammatory bowel diseases.

nL4N3J00R3

** UK's competition regulator said it has cleared U.S. medical equipment maker Thermo Fisher Scientific's TMO.N $3.1 billion deal to buy Swedish biotech firm Olink Holding AB OLK.O.

nL4N3J00Q1

** Carlsberg CARLb.CO has agreed to buy British soft drinks maker Britvic BVIC.L for 3.3 billion pounds ($4.23 billion), a move the Danish brewer said would forge a UK beverage "powerhouse" and that sent both companies' shares higher.

nL4N3J00DT

** The Grifols family and Canadian fund Brookfield have agreed to launch a joint takeover bid for Spanish drugmaker Grifols GRLS.MC with the intent to delist it, the companies said in regulatory filings.

nL1N3J0081


** Attica Bank BOAr.AT, Greece's fifth largest lender, announced an initial agreement to merge with the smaller Pancretan Bank in an effort to clean up its balance sheet and create a new banking organisation.

nL8N3IW0M6


(Compiled by Rajarshi Roy and Christy Santhosh in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.